C$ RQB U$ RVVQF · 2018. 3. 20. · 750,000 kg supply shortfall in 2018 2 THE OPPORTUNITY Combined...
Transcript of C$ RQB U$ RVVQF · 2018. 3. 20. · 750,000 kg supply shortfall in 2018 2 THE OPPORTUNITY Combined...
C O R P O R A T E P R E S E N T A T I O NMARCH 2018
C$ RQB
U$ RVVQF
This presentation contains forward-looking statements. These forward-looking statements are not based on historical facts but rather on company
expectations regarding future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and
sources of funding thereof), competitive advantages, Business prospects and opportunities. Statements in this presentation about future plans and
intentions, results, level of activity, performance, goals or achievements or other future events constitute forward-looking statements. Wherever
possible, words such as “anticipate:, “believe”, “expect”, “may”, “could”, “will”, “forecast”, “potential”, “intend”, “estimate”, “should”, “plan”,
“predict”, or the negative or other variations of statements reflects managements’ current beliefs and assumptions and are based on information
currently available to the Company management. Certain risk factors may cause actual results, level of activity, performance or achievements to
differ materially from those implied by forward-looking statements. These factors should be considered carefully and prospective investors should not
place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this presentation are based upon
what the Company management believes to be reasonable assumptions, investors cannot be assured that actual results will be consistent with these
forward-looking statements. These forward-looking statements are made as of the date of this presentation and the Company assumes no obligation
to update or revise them to reflect new events or circumstances.
F O R W A R D L O O K I N G S T A T E M E N T
2
A $7.8 Billion Market by 2021T H E O P P O R T U N I T Y
Medical and recreational Cannabis Sectors will generate annual
revenues of $1.8 billion and $6 billion respectively by 20211
1 Cannacord Genuity
750,000 kg supply shortfall in 20182
T H E O P P O R T U N I T Y
Combined 2018 demand will be 1 million kg of Canabis, while supply will be about 300,000 kg, Representing a near-term annual supply shortfall of 700,000 kg. We expect demand will continue to increase for several years.
This represents a huge opportunity for producers who are currently or about to become licensed to produce.2 Health Canada
1,000,000 kgD E M A N D
300,000 kgS U P P L Y
M E D I C A L M A R K E T
• The number of patients is growing at approximately
30% per quarter3
• Licensed producers are contributing to growth of the
market through• Increased attendance at medical industry conferences
• Individual physician engagement
• development of cannabis-specific continuing medical education
programs
3 Health Canada
O V E R A L L M A R K E T S I Z E
• Recreational sales in Canada may reach $6
billion by 20214 as the legal market is replaced
with the regulated adult use market
• Patients in Canada will consume more than
150,000 kg of medical cannabis by the year 2021,
Which could equate to $1.8 billion in retail sales4
• Base retail cannabis market in Canada is
estimated to be between $4.9 billion and $8.7
billion.5
4 Cannacord Genuity Group Inc.5 Deloitte – Recreational Marijuana Insights and Opportunities
G E O R G E R O B I N S O N
• Highest level adviser and consultant to multiple licensed cannabis producers
since the MMPR (predecessor to the ACMPR) was introduced in 2013
• Instrumental in helping a lengthy list of producers meet and/ or maintain
the rigorous standards of compliance set out by Health Canada
• Seen by many as visionary with an in-depth understanding of the
myriad aspects of this emerging industry: facility design, product
safety & efficiency, market acceptance & development, product
evolution
R Q B ’ S T W O D I S T I N C T D I V I S I O N S
SERVICES DIVISION: ESTABLISHED
• Key adviser to extensive and reputable list of clients
• End-to-end solution provider for existing LPs and late-stage
applicants
• Facility design, construction
• Proprietary, industry-leading growing and drying
technologies
INVESTMENT / ACQUISITION DIVISION
• Bloomera 20,000 sq foot Licensed facility: 4,000 kg/year
• AGB 35,500 sq foot, 7,000 kg/year production facility
completed mid-2018
• 11,000 kg/year production by late 2018
• Strategically positioned for expansion due to consultancy
relationships
• Focus on partnerships with Indigenous Peoples
I N V E S T M E N T / A C Q U I S I T I O N D I V I S I O N
• Acquired Bloomera, 20,000 square foot Licensed Producer; 2,200 kg current production
• 4,000 kg annual production with Orbital Garden grow technology
• First acquisition: Alberta Green Biotech
• 35,500 square foot Edmonton facility currently under construction
• additional land to expand the facility to more than double capacity as a second stage
• AGB Phase 1 construction budget is in range of $14 million to $16 million
• Completion of facility targeted at mid 2018
• Expected to produce 7,000 kg of cannabis annually – Industry leading GRAMS PER SQUARE FOOT
• Combined annual production with Orbital Garden grow technology: 11,000 kg per annum
• CONTINUED EXPANSION A PRIORITY
P R O P R I E T A R Y I N D U S T R Y - L E A D I N G T E C H N O L O G YAutomated Orbital Garden 2.0 can double existing yield standards
I N D I G E N O U S P E O P L E S P A R T N E R S H I P S
• Bill Robinson leads Government/ Indigenous Relations and Strategic Partnerships
• 34 years with RCMP, retired as commanding officer “D” Division
• Former President and CEO, Alberta Gaming & Liquor Commission (AGLC) - Alberta Gaming and Liquor Commission
will serve as the central wholesaler for all cannabis product sold in Alberta
• Extensive relationships with Indigenous Peoples across Canada
• Favorable taxation regime for facility construction, cannabis production & sale on sovereign
Indigenous lands
• Healthy pipeline of engagements with Indigenous Peoples
• Contract to build 24,000 square foot facility for Fort McMurray First Nation #468 announced
November 2017
I N D I G E N O U S P E O P L E S C A N N A B I S A S S O C I A T I O N
• Works collectively with Indigenous Communities across the country. The association coordinates business
opportunities for its members by speaking with one voice to the Government of Canada surrounding Medical
Marijuana production
• Presents a united voice for Indigenous Cannabis Producers across Canada when interacting with federal and
provincial government bodies
• Provides a clearing house for new ideas related to the Indigenous production and sale of cannabis coast to
coast to coast
I N D I G E N O U S P E O P L E S P A R T N E R S H I P S
• Land assessment, zoning, geotechnical
• Step-by-step guidance through the complex Health Canada application process
• Facility design, construction, and security
• Plant genetics
• Proprietary growing, drying, monitoring technologies
RQB’S TURN KEY CANNABIS SOLUTION:
S E R V I C E S D I V I S I O N : I N D U S T R Y E X P E R T I S E
• Delivers comprehensive, integrated solutions to companies in the
regulated cannabis market in Canada
• Proprietary, automated systems for growing, drying, monitoring
designed specifically for cannabis yield maximization
• Unmatched industry best practices
C O M P L I A N C E
• Compliance with Health Canada regulations will be a key determinant of success and profitability
• Proprietary growing and drying technologies, patient engineering management systems, and security systems
ensure compliance which will be unsurpassed in the cannabis industry, greatly reducing risk of shutdowns or
recalls
I N D U S T R Y D I S R U P T I V E R & D
• RavenQuest BioMed recently announced a landmark research
partnership with McGill University
• The work will be conducted through collaboration between two
McGill laboratories
• Dr. Donald Smith - patented technologies for improvement of crop
yields
• Dr. Mark Ware - medical cannabis researcher; Director of clinical
research at the Allen Edwards Pain Management Unit at the McGill
University Health Center (MUHC)
F O U R P I L L A R S A P P R O A C H
Turnkey Indigenous
Peoples Cannabis Offering
Investment Division:
Bloomera +
Alberta Green Biotech
= 11,000 kg/year
Immediate Revenue
Cash Flow Positive
Services Division
R&D Initiatives
Partnered with McGill University
M A R K E T R E C E P T I O N
GEORGE ROBINSONCEO & Director
• Recognized specialist in the cannabis sector and has worked directly with the CL2G Group’s
clients and health Canada in all stages of the application and licensing process under the
ACMPR and its predecessor legislation, the MMPR
• Extensive experience in building design, municipal bylaw compliance, heating, ventilation
and air conditioning, cannabis growing and drying strategies, security, data collection and
analysis, and project funding
• B.C. Licensed security consultant, Black Belt Six Sigma certified and current president of the
BC Regional Council of the Canadian Security Association
E X E C U T I V E T E A M
DAVID CROSSCPA, CGA, Chief Financial Officer
• 20 years of public practice with cross Davis and Company, LLP
• CFO of numerous TSX and TSXV issuers
MARLA RITCHIECorporate Secretary
• 25 years of public markets expertise
BILL ROBINSONManager, Government & Indigenous Relations
• 34 years RCMP, Retired Commander “D” division
• Former President & CEO, Alberta Gaming & Liquor Commission
BENILDA SABLEManager, Quality Assurance
• Sought after industry consultant for major Hemp growers and
processors in Canada and worldwide
• Advisor to major Hemp processing facilities domestically and
abroad
B O A R D O F D I R E C T O R S
CHRIS BECHTEL Director
• Over 30 years experience, as an executive, entrepreneur and consultant,
managing and advising businesses from startups to divisions of large
Fortune 500 companies
• Form and chairman of Supreme Pharmaceuticals, Inc., one of first
Canadian public companies in the cannabis sector
TONY DRESCHER CPA, CMA, Director
• Over 35 years experience as an executive and in various industries
including mining, telecommunications, technology and waste
management
• Currently serves on the Board of Directors of several private and public
companies
DR. JORGE BONET Director
• Director of the Atrial Fibrillation Clinic at The Royal Columbian Hospital
• Received international awards for original research as well as grand support
from major foundations
• Principal investigator in multiple major international randomized clinical
studies
HENDRIK (HENK) VAN ALPHEN Director
• Proven leader with experience in funding, building and operating numerous
companies in the resource sector
• Extensive experience in international mergers & acquisitions
• Has been involved in financing and transactions totaling well over $1 billion
in his career
• Canadian public companies experience - has held the executive
management and board positions with multiple issuers
Shares Issued and Outstanding
Share Price (March 2018)
Market Capitalization
92,796,832
C$1.35
C$125 Million
• Experience management team who are recognized leaders in the cannabis industry
• Unique, two-pronged business model diversifies risk
• Assets generating cash flow today
• End-to-end solutions for cannabis industry
• Longer-term upside through strategic investments in LPs
• Business model is not reliant on timing of recreational market rollout
• Large and growing market - not creating demand but transferring from illicit to legal
• Strong shareholder base and access to capital for growth
I N V E S T M E N T H I G H L I G H T S
T H A N K Y O U
Mathieu McDonald
Corporate CommunicationsRavenquest BioMed Inc.
Suite 2300 – 1177 West Hastings Street, Vancouver BC, Canada, V6E 2K3
604-484-1230 | [email protected]